TNYA
Tenaya Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$0.82+0.15%
Price as of Jul 20, 2026
TNYA profitability
Tenaya Therapeutics, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 144.9%
- EBITDA margin
- —
- EBIT margin
- —
- Net margin
- —
- Free cash flow margin
- —
Returns
- Return on equity
- -78.2%
- Return on assets
- -61.5%
- Return on invested capital
- -73.8%
- Asset turnover
- 0.00x
Cash efficiency
- Cash from operations
- -$64.4M
- Cash per share
- $0.37
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.